İleri Glikasyon Son Ürünleri ve Böbrek Hastalıkları

Year 2018, Volume: 7 Issue: 1, 210 - 217, 31.03.2018

Yağmur Demirel Hilal Yıldıran

Abstract

İleri
glikasyon son ürünleri (AGE) karbonhidratların karbonil grubu ve amino
asitlerin serbest amino gruplarının bir araya gelmesi ile maillard reaksiyonu
sonucunda oluşan ürünlerdir. AGE oluşumu oldukça karmaşık bir süreçtir ve bu
süreçte sadece karbonhidratlar ve amino asitler yer almamaktadır. Oksidatif
stres ve karbonil stres gibi birçok faktör AGE oluşumunu tetiklemektedir. AGE
oluşum süreci yavaş ilerler. AGE oluşum sürecinde dokuların protein yapısına
zarar verir.

AGE metabolizmasında böbreklerin yeri oldukça önemlidir. AGE’lerin
serum seviyesini sabit tutulması ve vücuttan uzaklaştırılmasında böbrekler görev
almaktadır. Böbrekte kaynaklanan herhangi bir bozukluk veya herhangi bir hasar
AGE seviyelerinde artışa neden olmakta ve serum AGE seviyesindeki artışa bağlı
olarak üremik komplikasyonlar görülebilmektedir. İlerleyen böbrek yetmezliğinde
AGE seviyesi gittikçe artmakta ve böbrek fonksiyonlarının daha da azalmasına
neden olarak kısır bir döngü oluşmaktadır. Diyaliz ve böbrek transplantasyonu
ise serum AGE seviyelerini azaltan tedavilerdir.

Keywords

İleri Glikasyon Son Ürünleri, Beslenme, Böbrek Hastalıkları

References

• KAYNAKLAR 1. Maillard, L. C. (1912). “Action des acidesamines sur les sucres: formation des melanoidines par voie methodique”. CR Acad. Sci.(Paris), 154, 66-68. 2. Parmaksiz, I. (2011). “Advanced glycation end-products in complications of diabetes mellitus”. Marmara Med J 2011; 24: 141-8. 3. Dyer, D. G., Dunn, J. A., Thorpe, S. R., Bailie, K. E., Lyons, T. J., McCance, D. R., et al (1993). “Accumulation of Maillard reaction products in skin collagen in diabetes and aging”. Journal of Clinical Investigation, 91(6), 2463. 4. Miyata, T., Ueda, Y., Shinzato, T., Iida, Y., Tanaka, S., Kurokawa, K., et al. (1996). “Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine”. Journal of the American Society of Nephrology, 7(8), 1198-1206. 5. Münch, G., Gerlach, M., Sian, J., Wong, A., and Riederer, P. (1998). “Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress?” Annals of Nurology, 44(S1). 6. Nowotny, K., Jung, T., Höhn, A., Weber, D., and Grune, T. (2015). “Advanced glycation end products and oxidative stress in type 2 diabetes mellitus”. Biomolecules, 5(1), 194-222. 7. Kılınç, K. (2011). “Protein glikasyonu”. Hacettepe Tıp Dergisi, 42,95-104.8. Verzijl, N., DeGroot, J., Thorpe, S. R., Bank, R. A., Shaw, J. N., Lyons, T., et al (2000). “Effect of collagen turnover on the accumulation of advanced glycation end products.” Journal of Biological Chemistry, 275(50), 39027-39031. 9. Miyata, T., Ueda, Y., Horie, K., Nangaku, M., Tanaka, S., Strihou, C., et al (1998). “Renal catabolism of advanced glycation end products: the fate of pentosidine”. Kidney İnternational, 53(2), 416-422. 10. Vlassara, H., and Uribarri, J. (2004). “Glycoxidation and diabetic complications: modern lessons and a warning? Reviews in endocrine and metabolic disorders”. 5(3), 181-188. 11. Aronson, D. (2003). “Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. Journal of Hypertension”. 21(1), 3-12. 12. Solís-Calero, C., Ortega-Castro, J., Frau, J., and Muñoz, F. (2015). “Nonenzymatic reactions above phospholipid surfaces of biological membranes: reactivity of phospholipids and their oxidation derivatives. Oxidative medicine and cellular longevity”. 2015. 13. Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., and Hakim, R. M. (2002). “The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia”. Kidney İnternational, 62(5), 1524-1538. 14. Miyata, T., Strihou, C. Y., Kurokawa, K., and Baynes, J. W. (1999). “Alterations in nonenzymatic biochemistry in uremia: origin and significance of “carbonyl stress” in long-term uremic complications”. Kidney İnternational, 55(2), 389-399. 15. Singh, R., Barden, A., Mori, T., and Beilin, L. (2001). “Advanced glycation end-products: a review. Diabetologia”. 44(2), 129-146. 16. Cai, W., He, J. C., Zhu, L., Peppa, M., Lu, C., Uribarri, J.,et al. (2004). “High levels of dietary advanced glycation end products transform low-dersity lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients”. Circulation, 110(3), 285-291. 17. Lin, R.-Y., Choudhury, R. P., Cai, W., Lu, M., Fallon, J. T., Fisher, E. A., et al (2003). “Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice”. Atherosclerosis, 168(2), 213-220. 18. Zheng, F., He, C., Cai, W., Hattori, M., Steffes, M., and Vlassara, H. (2002). “Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products”.Diabetes/Metabolism Research and Reviews, 18(3), 224-237. 19. Goldberg, T., Cai, W., Peppa, M., Dardaine, V., Baliga, B. S., Uribarri, J., et al. (2004). “Advanced glycoxidation end products in commonly consumed foods”. Journal of the American Dietetic Association, 104(8), 1287-1291. 20. Levi, B., and Werman, M. J. (2003). “Fructose and related phosphate derivatives impose DNA damage and apoptosis in L5178Y mouse lymphoma cells”. The Journal of Nutritional Biochemistry, 14(1), 49-60. 21. Ahmed, N., Mirshekar‐Syahkal, B., Kennish, L., Karachalias, N., Babaei‐Jadidi, R., and Thornalley, P. J. (2005). “Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection”. Molecular Nutrition and Food Research, 49(7), 691-699. 22. Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., et al. (2010). “Advanced glycation end products in foods and a practical guide to their reduction in the diet”. Journal of the American Dietetic Association, 110(6), 911-916. 23. Lo, C.Y., Li, S., Wang, Y., Tan, D., Pan, M.-H., Sang, S., et al. (2008). “Reactive dicarbonyl compounds and 5-(hydroxymethyl)-2-furfural in carbonated beverages containing high fructose corn syrup”. Food Chemistry, 107(3), 1099-1105. 24. Cai, W., Gao, Q.D., Zhu, L., Peppa, M., He, C., and Vlassara, H. (2002).” Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction”. Molecular Medicine, 8(7), 337. 25. Cai, W., He, J.C., Zhu, L., Chen, X., Zheng, F., Striker, G.E., et al. (2008). “Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan”. The American Journal of Pathology, 173(2), 327-336. 26.Baynes, J. W. (2002). “The Maillard hypothesis on aging: time to focus on DNA”. Annals of the New York Academy of Sciences, 959(1), 360-367. 27. Raj, D. S., Choudhury, D., Welbourne, T. C., and Levi, M. (2000). Advanced glycation end products: a Nephrologist's perspective. American Journal of Kidney Diseases, 35(3), 365-380. 28. Ramasamy, R., Yan, S. F., and Schmidt, A. M. (2012). “Advanced glycation endproducts: from precursors to RAGE: round and round we go”. Amino acids, 42(4), 1151-1161. 29.Bierhaus, A., Humpert, P.M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., et al. (2005). “Understanding RAGE, the receptor for advanced glycation end products”. Journal of Molecular Medicine, 83(11), 876-886.30. Peppa, M., Brem, H., Ehrlich, P., Zhang, J.G., Cai, W., Li, Z., et al. (2003). “Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice”. Diabetes, 52(11), 2805-2813. 31. Wautier, J.L., and Schmidt, A. M. (2004). “Protein glycation”. Circulation Research, 95(3), 233-238. 32. Van Dijk, P.C., Jager, K.J., Stengel, B., Gronhagen-Riska, C., Feest, T.G., and Briggs, J. D. (2005). “Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991–2000)”. Kidney İnternational, 67(4), 1489-1499. 33. Wendt, T., Tanji, N., Guo, J., Hudson, B. I., Bierhaus, A., Ramasamy, R., et al. (2003). “Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy”. Journal of the American Society of Nephrology, 14(5), 1383-1395. 34. Kanauchi, M., Nishioka, H., and Dohi, K. (2001). “Serum levels of advanced glycosylation end products in diabetic nephropathy”. Nephron, 89(2), 228-230. 35. Lutgers, H.L., Graaff, R., Links, T.P., Ubink-Veltmaat, L.J., Bilo, H.J., Gans, R. O., et al. (2006). “Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes”. Diabetes Care, 29(12), 2654-2659. 36. Agarwal, R., Campbell, R.C., and Warnock, D. G. (2004). "Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Paper presented at the Seminars in nephrology". Seminars in Nephrology, 24(2),101-114.
• 37. Hudson, B.I., Stickland, M.H., Futers, T. S., and Grant, P.J. (2001). "Study of the− 429 T/C and− 374 T/A receptor for advanced glycation end products promoter polymorphisms in diabetic and nondiabetic subjects with macrovascular disease". Diabetes Care, 24(11), 2004-2004. 38. Miyata, T., Ueda, Y., Yamada, Y., Izuhara, Y., Wada, T., Jadoul, M.,. et al. (1998). "Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia". Journal of the American Society of Nephrology, 9(12), 2349-2356. 39. Bohlender, J.M., Franke, S., Stein, G., and Wolf, G. (2005). "Advanced glycation end products and the kidney. American Journal of Physiology-Renal Physiology, 289(4), F645-F659. 40. Kalousova, M., Zima, T., Tesař, V., Štípek, S., and Sulkova, S. (2004). "Advanced glycation end products in clinical nephrology". Kidney and Blood Pressure Research, 27(1), 18-28. 41. Zeier, M., Schwenger, V., Deppisch, R., Haug, U., Weigel, K., Bahner, U., et al. (2003). "Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?". Kidney İnternational, 63(1), 298-305. 42. Tauer, A., Zhang, X., Schaub, T.P., Zimmeck, T., Niwa, T., Passlick-Deetjen, J., et al. (2003). "Formation of advanced glycation end products during CAPD". American Journal of Kidney Diseases, 41(3), S57-S60. 43.Baragetti, I., Furiani, S., Vettoretti, S., Raselli, S., Maggi, F., Galli, F., et al. (2006). "Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: a pilot study". Blood Purification, 24(4), 369-376. 44. Hartog, J.W., de Vries, A. P., Bakker, S. J., Graaff, R., van Son, W. J., van der Heide, J.J.H., et al. (2006). "Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients". Nephrology Dialysis Transplantation, 21(8), 2263-2269. 45.Bakris, G.L., Bank, A.J., Kass, D.A., Neutel, J.M., Preston, R.A., and Oparil, S. (2004). "Advanced glycation end-product cross-link breakers: a novel approach to cardiovascular pathologies related to the aging process". American Journal of Hypertension, 17(12), S23-S30. 46. Hammes, H.P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., et al. (2003). "Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy". Nature Medicine, 9(3), 294-299. 47. Uribarri, J., Cai, W., Peppa, M., Goodman, S., Ferrucci, L., Striker, G., et al. (2007). "Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging". The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 62(4), 427-433. 48. Uribarri, J., Peppa, M., Cai, W., Goldberg, T., Lu, M., and Vlassara, H. (2003). "Restriction of glycotoxins markedly reduces AGE toxins in renal failure patients". J Am Soc Nephrol, 14, 728-731. 49. AICR. (2008). World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: A Global perspective: American Institute for Cancer Research Washington DC Washington DC.50.Bantle, J. P., Wylie-Rosett, J., Albright, A. L., Apovian, C. M., Clark, N. G., Franz, M. J., et al. (2008). "Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association". Diabetes Care, 31, S61-S78. 51. Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., et al. (2006). "Diet and lifestyle recommendations revision 2006". Circulation, 114(1), 82-96.